≡

Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A)

[Edit]

ARP3; A3A; PHRBN; Phorbolin I; DNA dC->dU-editing enzyme APOBEC-3A

Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A)
CCC L205
HGNC 17343
PubMed 23695684
UniProt P31941
Wiki APOBEC3A
APOBEC3A is a cytidine deaminase with antiviral effects. While other members of the family such as APOBEC3G are believed to act by editing ssDNA or RNA by removing an amino group from cytidine, introducing a cytidine to uracil mutation, recent studies show that APOBEC3A inhibits parvoviruses by another mechanism.
The cellular function of APOBEC3A is likely to be the destruction of foreign DNA through extensive deamination of cytosine. This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A) CLIA Kit Customized Service Offer
n/a ELISA Kit for Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide 3A (APOBEC3A) ELISA Kit Customized Service Offer
  1. "Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1."J. Invest. Dermatol. 113:162-169(1999) [PubMed] [Europe PMC] [Abstract]
  2. "A genome annotation-driven approach to cloning the human ORFeome."Genome Biol. 5:R84.1-R84.11(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The DNA sequence of human chromosome 22." Nature 402:489-495(1999) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes."Electrophoresis 13:960-969(1992) [PubMed] [Europe PMC] [Abstract]
  6. "An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22."Genomics 79:285-296(2002) [PubMed] [Europe PMC] [Abstract]
  7. "Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business."Trends Genet. 19:207-216(2003) [PubMed] [Europe PMC] [Abstract]
  8. "Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif."Cell 114:21-31(2003) [PubMed] [Europe PMC] [Abstract]
  9. "APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons."Curr. Biol. 16:480-485(2006) [PubMed] [Europe PMC] [Abstract]
  10. "The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements."Annu. Rev. Immunol. 26:317-353(2008) [PubMed] [Europe PMC] [Abstract]
  11. "Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase."PLoS Pathog. 5:E1000439-E1000439(2009) [PubMed] [Europe PMC] [Abstract]
  12. "Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms."J. Biol. Chem. 285:27753-27766(2010) [PubMed] [Europe PMC] [Abstract]
  13. "APOBEC3 proteins mediate the clearance of foreign DNA from human cells."Nat. Struct. Mol. Biol. 17:222-229(2010) [PubMed] [Europe PMC] [Abstract]
  14. "Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction."Nucleic Acids Res. 38:4274-4284(2010) [PubMed] [Europe PMC] [Abstract]
  15. "Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain."Cell 145:423-434(2011) [PubMed] [Europe PMC] [Abstract]
  16. "APOBEC3A can activate the DNA damage response and cause cell-cycle arrest."EMBO Rep. 12:444-450(2011) [PubMed] [Europe PMC] [Abstract]
  17. "Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities."J. Virol. 85:1765-1776(2011) [PubMed] [Europe PMC] [Abstract]
  18. "Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1."J. Virol. 85:11220-11234(2011) [PubMed] [Europe PMC] [Abstract]
  19. "Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism."Proc. Natl. Acad. Sci. U.S.A. 108:4858-4863(2011) [PubMed] [Europe PMC] [Abstract]
  20. "Cytosine deaminases APOBEC3A, APOBEC3C, and APOBEC3H: Current understanding of their functional roles."Student Perspec. Contemp. Virol. 0:0-0(2011)
  21. "Retroelements versus APOBEC3 family members: No great escape from the magnificent seven."Front. Microbiol. 3:275-275(2012) [PubMed] [Europe PMC] [Abstract]
  22. "Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A."J. Biol. Chem. 287:34801-34808(2012) [PubMed] [Europe PMC] [Abstract]
  23. "Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A."J. Biol. Chem. 287:39182-39192(2012) [PubMed] [Europe PMC] [Abstract]
  24. "APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1."J. Virol. 86:6097-6108(2012) [PubMed] [Europe PMC] [Abstract]
  25. "HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies."J. Virol. 86:11712-11724(2012) [PubMed] [Europe PMC] [Abstract]
  26. "Functions and regulation of the APOBEC family of proteins."Semin. Cell Dev. Biol. 23:258-268(2012) [PubMed] [Europe PMC] [Abstract]